Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

dinapsoline

Known as: 8,9-dihydroxy-2,3,7,11b-tetrahydro-1H-napth(1,2,3-de)isoquinoline 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders Na Ye,† John L. Neumeyer,‡ Ross J… Expand
  • figure 1
  • table 1
  • figure 3
  • table 2
  • figure 4
2012
2012
Although functional selectivity is now widely accepted, the molecular basis is poorly understood. We have studied how aspects of… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Review
2009
Review
2009
The dopamine (DA) D1 receptor is the most highly expressed DA receptor subtype among the DA receptor family. Although the first… Expand
2004
2004
Dinapsoline is a full D(1) dopamine receptor agonist that produces robust rotational activity in the unilateral 6-OHDA rat model… Expand
2004
2004
The synthesis and preliminary pharmacological evaluation of 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (5… Expand
2003
2003
Dinapsoline ((2); (+/-)-dihydroxy-2,3,7,11b-tetrahydro-1H-naphth[1,2,3-de]isoquinoline) is a full D(1) dopamine agonist that also… Expand
2002
2002
A highly convergent synthesis was developed for the novel dopamine agonist dinapsoline (12) (Ghosh, D.; Snyder, S. E.; Watts, V… Expand
2001
2001
Dinapsoline is a new potent, full agonist at D1 dopamine receptors with limited selectivity relative to D2 receptors. The… Expand
Highly Cited
1998
Highly Cited
1998
The role of drug efficacy in agonist-induced desensitization was studied in C-6 glioma cells transfected with the monkey dopamine… Expand
1996
1996
The present work reports the synthesis and preliminary pharmacological characterization of 8,9-dihydroxy-2,3,7,11b-tetrahydro-1H… Expand